Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease

This study is ongoing, but not recruiting participants.

Study NCT00032279 Information provided by Facet Biotech

First Received: March 14, 2002 Last Updated: History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given